Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

SCH 530348: a novel oral thrombin receptor antagonist.

SCH 530348: a novel oral thrombin receptor antagonist. Future Cardiol. 2009 Sep; 5(5):435-42.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.